Comment on 'Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)'.
Tokyo Women's Medical University, Medical Center East, Obstetrics and Gynecology, 2-1-10 Nishiogu, Arakawa-ku, Tokyo, Japan.
H
H
Nagano
D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D005260:Female; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000628:therapy*